Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Triangular test and randomized trials: practical problems in a small cell lung cancer trial

J P Pignon1, M Tarayre, A Auquier

  • 1Department of Biostatistics and Epidemiology, Institut Gustave-Roussy, Villejuif, France.

Statistics in Medicine
|July 15, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

[Comparison of mortality of lung cancer resections in France to other European countries].

Revue des maladies respiratoires·2022
Same author

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.

ESMO open·2021
Same author

Somatic profile in lung cancers is associated to reproductive factors in never-smokers women: Results from the IFCT-1002 BioCAST study.

Respiratory medicine and research·2020
Same author

Vemurafenib in non-small-cell lung cancer patients with BRAF<sup>V600</sup> and BRAF<sup>nonV600</sup> mutations.

Annals of oncology : official journal of the European Society for Medical Oncology·2020

The triangular test monitored small cell lung cancer trial survival data. Statistical stopping rules require caution; independent committees aid trial decisions.

Area of Science:

  • Oncology
  • Biostatistics
  • Clinical Trials

Background:

  • Small cell lung cancer (SCLC) survival data monitoring is critical.
  • Randomized trials require robust interim analysis methods.
  • Data Monitoring Committees (DMCs) play a key role in trial oversight.

Purpose of the Study:

  • To describe the application of the triangular test for monitoring SCLC trial survival data.
  • To highlight challenges faced by DMCs and coordinators during interim analyses.
  • To discuss the implications of early trial cessation on statistical analysis and outcomes.

Main Methods:

  • Utilized the triangular test for sequential monitoring of survival data.
  • Conducted consecutive interim analyses throughout the randomized trial.

Related Experiment Videos

  • Documented issues encountered by the data monitoring committee and trial coordinators.

    • Main Results:

    • The triangular test was applied to monitor survival in an SCLC randomized trial.
    • Interim analyses revealed challenges in data monitoring and coordination.
    • Early stopping decisions were influenced by various factors beyond statistical rules.

    Conclusions:

    • Statistical stopping rules should be used cautiously in clinical trials.
    • Independent data monitoring committees are valuable for reviewing trial progress.
    • DMCs provide essential advice to trial participants and stakeholders.